Abstract
Ga-labeled prostate-specific membrane antigen ligand PET-CT has emerged as a promising technique to evaluate the extent of disease in patients with prostate carcinoma. We are reporting a 63-year-old man with prostatic carcinoma subjected to Ga-prostate-specific membrane antigen ligand PET-CT for initial staging. In addition to the radiotracer uptake in known primary site (prostate), focal increased radiotracer uptake was also noticed in the left breast. Subsequent biopsy of the breast lesion revealed PASH (pseudoangiomatous stromal hyperplasia), which is a benign mesenchymal proliferative lesion that may present clinically as palpable mass requiring further evaluation to rule out malignancy.
MeSH terms
-
Angiomatosis / complications
-
Angiomatosis / diagnostic imaging*
-
Angiomatosis / pathology
-
Biopsy, Large-Core Needle
-
Breast / diagnostic imaging*
-
Breast / pathology
-
Breast Diseases / complications
-
Breast Diseases / diagnostic imaging*
-
Breast Diseases / pathology
-
Carcinoma / complications
-
Carcinoma / diagnostic imaging*
-
Edetic Acid / analogs & derivatives
-
Gallium Isotopes
-
Gallium Radioisotopes
-
Humans
-
Hyperplasia / complications
-
Hyperplasia / diagnostic imaging*
-
Hyperplasia / pathology
-
Male
-
Middle Aged
-
Oligopeptides
-
Organometallic Compounds
-
Prostatic Neoplasms / complications
-
Prostatic Neoplasms / diagnostic imaging*
-
Radiopharmaceuticals
Substances
-
Gallium Isotopes
-
Gallium Radioisotopes
-
Oligopeptides
-
Organometallic Compounds
-
Radiopharmaceuticals
-
gallium 68 PSMA-11
-
Edetic Acid
Supplementary concepts
-
Pseudoangiomatous stromal hyperplasia